Evolutionary aspects of ABO blood group in humans

Clinica Chimica Acta

Volumn 444, Issue , 2015, Pages 66-71

  Franchini, Massimo ^a   Bonfanti, Carlo ^a  

^a CARLO POMA HOSPITAL   (Italy)

Author keywords

ABO blood group; Cancers; Cardiovascular diseases; Infections; Longevity

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD GROUP ANTIGEN; VON WILLEBRAND FACTOR; BLOOD GROUP ABO SYSTEM;

AGING; ALZHEIMER DISEASE; BLEEDING; BLOOD GROUP ABO SYSTEM; CARDIOVASCULAR DISEASE; COGNITIVE DEFECT; DISEASE ASSOCIATION; EVOLUTION; EVOLUTIONARY ADAPTATION; GENETIC ASSOCIATION; HUMAN; INFECTION; INFECTION SENSITIVITY; LONGEVITY; NEOPLASM; NONHUMAN; PARKINSON DISEASE; REVIEW; RISK FACTOR; THROMBOSIS; DISEASES; GENETICS;

ABO BLOOD-GROUP SYSTEM; BIOLOGICAL EVOLUTION; DISEASE; HUMANS; LONGEVITY;

EID: 84923005621     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2015.02.016     Document Type: Review

References (86)

1. Landsteiner K. Zur kenntnis der antifermentativen, lytischen und agglutinierenden wirkungendes des blutserums und der lymphe. Zentralbl Bakteriol 1900, 27:357-363.
2. Storry J.R., Olsson M.L. The ABO blood group system revisited: a review and update. Immunohematology 2009, 25:48-59.
3. Yamamoto F. Review: ABO blood group system-ABH oligosaccharide antigens, anti-A and anti-B, A and B glycosyltransferases, and ABO genes. Immunohematology 2004, 20:3-22.
4. Yamamoto F., Cid E., Yamamoto M., Blancher A. ABO research in the modern era of genomics. Transfus Med Rev 2012, 26:103-118.
5. Lowe J. The blood group-specific human glycosyltransferases. Baillieres Clin Haematol 1993, 6:465-490.
6. Eastlund T. The histo-blood group ABO system and tissue transplantation. Transfusion 1998, 38:975-988.
7. Liumbruno G.M., Franchini M. Beyond immunohaematology: the role of the ABO blood group in human diseases. Blood Transfus 2013, 11:491-499.
8. Franchini M., Favaloro E.J., Targher G., Lippi G. ABO blood group, hypercoagulability, and cardiovascular and cancer risk. Crit Rev Clin Lab Sci 2012, 49:137-149.
9. Franchini M., Liumbruno G.M. ABO blood group: old dogma, new perspectives. Clin Chem Lab Med 2013, 51:1545-1553.
10. Zhang H., Mooney C.J., Reilly M.P. ABO blood groups and cardiovascular diseases. Int J Vasc Med 2012, 2012:641917.
11. Anstee D.J. The relationship between blood groups and disease. Blood 2010, 115:4635-4643.
12. Yamamoto F., Cid E., Yamamoto M., Saitou N., Jaume B., Blancher A. An integrative evolution theory of histo-blood group ABO and related genes. Sci Rep 2014, 4:6601.
13. Calafell F., Roubinet F., Ramírez-Soriano A., Saitou N., Bertranpetit J., Blancher A. Evolutionary dynamics of the human ABO gene. Hum Genet 2008, 124:123-135.
14. Athreya B.H., Coriell L.L. Relation of blood groups to infection. I. A survey and review of data suggesting possible relationship between malaria and blood groups. Am J Epidemiol 1967, 86:292-304.
15. Cserti C.M., Dzik W.H. The ABO blood group system and Plasmodium falciparum malaria. Blood 2007, 110:2250-2258.
16. Loscertales M.P., Owens S., O'Donnell J., et al. ABO blood group phenotypes and Plasmodium falciparum malaria: unlocking a pivotal mechanism. Adv Parasitol 2007, 65:1-50.
17. Rowe J.A., Opi D.H., Williams T.N. Blood groups and malaria: fresh insights into pathogenesis and identification of targets for intervention. Curr Opin Hematol 2009, 16:480-487.
18. Cserti-Gazdewich C.M., Mayr W.R., Dzik W.H. Plasmodium falciparum malaria and the immunogenetics of ABO, HLA, and CD36 (platelet glycoprotein IV). Vox Sang 2011, 100:99-111.
19. Panda A.K., Panda S.K., Sahu A.N., et al. Association of ABO blood group with severe falciparum malaria in adults: case control study and meta-analysis. Malar J 2011, 10:309.
20. Uneke C.J. Plasmodium falciparum malaria and ABO blood group: is there any relationship?. Parasitol Res 2007, 100:759-765.
21. Rowe J.A., Handel I.G., Thera M.A., et al. Blood group O protects against severe Plasmodium falciparum malaria through the mechanism of reduced rosetting. Proc Natl Acad Sci U S A 2007, 104:17471-17476.
22. Fry A.E., Griffiths M.J., Auburn S., et al. Common variation in the ABO glycosyltransferase is associated with susceptibility to severe Plasmodium falciparum malaria. Hum Mol Genet 2008, 17:567-576.
23. Timmann C., Thye T., Vens M., et al. Genome-wide association study indicates two novel resistance loci for severe malaria. Nature 2012, 489:443-446.
24. Aird I., Bentall H.H., Mehigan J.A., Roberts J.A. The blood groups in relation to peptic ulceration and carcinoma of colon, rectum, breast, and bronchus; an association between the ABO groups and peptic ulceration. Br Med J 1954, 2:315-321.
25. Boren T., Falk P., Roth K.A., et al. Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science 1993, 262:1892.
26. Dickey W., Collins J.S., Watson R.G., et al. Secretor status and Helicobacter pylori infection are independent risk factors for gastroduodenal disease. Gut 1993, 3:351-353.
27. Ishijima N., Suzuki M., Ashida H., et al. BabA-mediated adherence is a potentiator of the Helicobacter pylori type IV secretion system activity. Biol Chem 2011, 286:25256-25264.
28. Ruvoen-Clouet N., Belliot G., Le Pendu J. Noroviruses and histo-blood groups: the impact of common host genetic polymorphisms on virus transmission and evolution. Rev Med Virol 2013, 23:355-366.
29. Tan M., Jiang X. Histo-blood group antigens: a common niche for norovirus and rotavirus. Expert Rev Mol Med 2014, 16:e5.
30. Hutson A.M., Atmar R.L., Graham D.Y., Estes M.K. Norwalk virus infection and disease is associated with ABO histo-blood group type. J Infect Dis 2002, 185:1335-1337.
31. Tan M., Jiang X. Association of histo-blood group antigens with susceptibility to norovirus infection may be strain-specific rather than genogroup dependent [letter]. J Infect Dis 2008, 198:940-941.
32. Tan M., Jin M., Xie H., et al. Outbreak studies of a GII-3 and GII-4 norovirus revealed an association between HBGA phenotypes and viral infection. J Med Virol 2008, 80:1296-1301.
33. Harris J.B., Khan A.I., LaRocque R.C., et al. Blood group, immunity, and risk of infection with Vibrio cholerae in an area of endemicity. Infect Immun 2005, 73:7422-7427.
34. Glass R.I., Holmgren J., Haley C.E., et al. Predisposition for cholera of individuals with O blood group. Possible evolutionary significance. Am J Epidemiol 1985, 121:791-796.
35. Blackwell C.C., Dundas S., James V.S., et al. Blood group and susceptibility to disease caused by Escherichia coli O157. J Infect Dis 2002, 185:393-396.
36. Liumbruno G.M., Franchini M. Hemostasis, cancer, and ABO blood group: the most recent evidence of association. J Thromb Thrombolysis 2014, 38:160-166.
37. Wolpin B.M., Chan A.T., Hartge P., et al. ABO blood group and the risk of pancreatic cancer. J Natl Cancer Inst 2009, 101:424-431.
38. Rizzato C., Campa D., Pezzilli R., et al. ABO blood groups and pancreatic cancer risk and survival: results from the PANcreatic Disease ReseArch (PANDoRA) consortium. Oncol Rep 2013, 29:1637-1644.
39. Edgren G., Hjalgrim H., Rostgaard K., et al. Risk of gastric cancer and peptic ulcers in relation to ABO blood type: a cohort study. Am J Epidemiol 2010, 172:1280-1285.
40. Etemadi A., Kamangar F., Islami F., et al. Mortality and cancer in relation to ABO blood group phenotypes in the Golestan Cohort Study. BMC Med 2015, 13:8.
41. Franchini M., Frattini F., Crestani S., Bonfanti C., Lippi G. Von Willebrand factor and cancer: a renewed interest. Thromb Res 2013, 131:290-292.
42. Franchini M., Capra F., Targher G., Montagnana M., Lippi G. Relationship between ABO blood group and von Willebrand factor levels: from biology to clinical implications. Thromb J 2007, 5:14.
43. Jenkins P.V., O'Donnell J.S. ABO blood group determines plasma von Willebrand factor levels: a biologic function after all?. Transfusion 2006, 46:1836-1844.
44. Franchini M., Mannucci P.M. ABO blood group and thrombotic vascular disease. Thromb Haemost 2014, 112:1103-1109.
45. Wu O., Bayoumi N., Vickers M.A., Clark P. ABO(H) blood groups and vascular disease: a systematic review and meta-analysis. J Thromb Haemost 2008, 6:62-69.
46. Dentali F., Sironi A.P., Ageno W., et al. Non-O blood type is the commonest genetic risk factor for VTE: results from a meta-analysis of the literature. Semin Thromb Hemost 2012, 38:535-548.
47. Dentali F., Sironi A.P., Ageno W., Crestani S., Franchini M. ABO blood group and vascular disease: an update. Semin Thromb Hemost 2014, 40:49-59.
48. Dentali F., Sironi A.P., Ageno W., et al. Relationship between ABO blood group and hemorrhage: a systematic literature review and meta-analysis. Semin Thromb Hemost 2013, 39:72-82.
49. Koster T., Blann A.D., Briet E., et al. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 1995, 345:152-155.
50. Tufano A., Coppola A., Nardo A., et al. Non-O blood group as a risk factor for cerebral vein thrombosis. Thromb Haemost 2013, 110:197-199.
51. Dentali F., Di Minno M.N., Turato S., et al. Role of ABO blood group and of other risk factors on the presence of residual vein obstruction after deep-vein thrombosis. Thromb Res 2014, 134:264-267.
52. Franchini M., Makris M. Non-O blood group: an important genetic risk factor for venous thromboembolism. Blood Transfus 2013, 11:164-165.
53. Franchini M., Rossi C., Mengoli C., et al. ABO blood group and the risk of coronary artery disease. J Thromb Thrombolysis 2013, 36:286-287.
54. Franchini M., Rossi C., Frattini F., et al. ABO blood group and risk of peripheral arterial thrombosis in patients with atrial fibrillation: a single center survey. J Thromb Thrombolysis 2014, 38:30-31.
55. He M., Wolpin B., Rexrode K., et al. ABO blood group and risk of coronary heart disease in two prospective cohort studies. Arterioscler Thromb Vasc Biol 2012, 32:2314-2320.
56. Ohira T., Cushman M., Tsai M.Y., et al. ABO blood group, other risk factors and incidence of venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE). J Thromb Haemost 2007, 5:1455-1461.
57. Spiezia L., Campello E., Bon M., et al. ABO blood groups and the risk of venous thrombosis in patients with inherited thrombophilia. Blood Transfus 2013, 11:250-253.
58. Yang N., Zhang B., Xie L., et al. The association baseline NIH Stroke Scale score with ABO blood-subtypes in young patients with acute ischemic stroke. Atherosclerosis 2014, 236:144-149.
59. Gong P., Luo S.H., Li X.L., et al. Relation of ABO blood groups to the severity of coronary atherosclerosis: an Gensini score assessment. Atherosclerosis 2014, 237:748-753.
60. Franchini M., Crestani S., Frattini F., Mengoli C., Bonfanti C. Relationship between ABO blood group and bleeding complications in orally anticoagulated patients. J Thromb Haemost 2012, 10:1688-1691.
61. Franchini M., Rossi C., Mengoli C., et al. O blood group is a risk factor for severe mucosal hemorrhage in orally anticoagulated patients. J Thromb Thrombolysis 2013, 36:358-360.
62. Franchini M., Mannucci P.M. Hemophilia A in the third millennium. Blood Rev 2013, 27:179-184.
63. Strang R.R. ABO blood groups in Parkinson's disease. APMIS 1965, 65:653.
64. Chia L.G., Liu L.H. Parkinson's disease in Taiwan: an analysis of 215 patients. Neuroepidemiology 1992, 11:113-120.
65. Kak V.K., Gordon D.S. ABO blood groups and Parkinson's disease. Ulster Med J 1970, 39:132-134.
66. Renvoize E.B. ABO and rhesus blood groups in Alzheimer's disease. Age Ageing 1985, 14:43-45.
67. Alexander K.S., Zakai N.A., Gileltt S., et al. ABO blood type, factor VIII, and incident cognitive impairment in the REGARDS cohort. Neurology 2014, 83:1271-1276.
68. Quinn T.J., Gallacher J., Deary I.J., Lowe G.D., Fenton C., Stott D.J. Association between circulating hemostatic measures and dementia or cognitive impairment: systematic review and meta-analyses. J Thromb Haemost 2011, 9:1475-1482.
69. Franchini M., Lippi G. Factor V Leiden in women: a thrombotic risk factor or an evolutionary advantage?. Semin Thromb Hemost 2011, 37:275-279.
70. Franchini M., Mannucci P.M. Interactions between genotype and phenotype in bleeding and thrombosis. Haematologica 2008, 93:649-652.
71. Rizzo C., Caruso C., Vasto S. Possible role of ABO system in age-related diseases and longevity: a narrative review. Immun Ageing 2014, 11:16.
72. Cevenini E., Invidia L., Lescai F., et al. Human models of aging and longevity. Expert Opin Biol Ther 2008, 8:1393-1405.
73. Murray S. ABO groups and Rh genotypes in the elderly. Br Med J 1961, 2:1472-1474.
74. Sturgeon P., Beller S., Bates E. Study of blood group factors in longevity. J Gerontol 1969, 24:90-94.
75. Vasto S., Caruso C., Castiglia L., Duro G., Monastero R., Rizzo C. Blood group does not appear to affect longevity a pilot study in centenarians from Western Sicily. Biogerontology 2011, 12:467-471.
76. Shimizu K., Hirose N., Ebihara Y., et al. Blood type B might imply longevity. Exp Gerontol 2004, 39:1563-1565.
77. Brecher M.E., Hay S.N. ABO blood type and longevity. Am J Clin Pathol 2011, 135:96-98.
78. Mengoli C., Bonfanti C., Rossi C., Franchini M. Blood group distribution and life-expectancy: a single-centre experience. Blood Transfus 2014, [Epub ahead of print].
79. Franchini M., Lippi G. The intriguing relationship between ABO blood group, cardiovascular disease and cancer. BMC Med 2015, 13:7.
80. Coppola R., Mari D., Lattuada A., Franceschi C. Von Willebrand factor in Italian centenarians. Haematologica 2003, 88:39-43.
81. Barbalic M., Dupuis J., Dehghan A., et al. Large-scale genomic studies reveal central role of ABO in sP-selectin and sICAM-1 levels. Hum Mol Genet 2010, 19:1863-1872.
82. Kiechl S., Paré G., Barbalic M., et al. Association of variation at the ABO locus with circulating levels of soluble intercellular adhesion molecule-1, soluble P-selectin, and soluble E-selectin: a meta-analysis. Circ Cardiovasc Genet 2011, 4:681-686.
83. Paterson A.D., Lopes-Virella M.F., Waggott D., et al. Genome-wide association identifies the ABO blood group as a major locus associated with serum levels of soluble E-selectin. Arterioscler Thromb Vasc Biol 2009, 29:1958-1967.
84. Naitza S., Porcu E., Steri M., et al. A genome-wide association scan on the levels of markers of inflammation in Sardinians reveals associations that underpin its complex regulation. PLoS Genet 2012, 8:e1002480.
85. Karakas M., Baumert J., Kleber M.E., et al. A variant in AB0 gene explains the variation in soluble E-selectin levels - results from dense genotyping in two independent populations. PLoS One 2012, 7:e51441.
86. Mathers C.D., Stevens G.A., Boerma T., White R.A., Tobias M.I. Causes of international increases in older age life expectancy. Lancet 2015, 385:540-548.